{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:26:15Z","timestamp":1792841175786,"version":"4.5.0"},"reference-count":28,"publisher":"The Journal of Rheumatology","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To evaluate the cardiovascular safety of abatacept (ABA) versus tumor necrosis factor inhibitors (TNFi) in rheumatoid arthritis (RA) patients with and without underlying cardiovascular disease (CVD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We identified RA patients with and without baseline CVD who initiated ABA or TNFi by using data from 2 large US insurance claims databases: Medicare (2008\u20132013) and Truven MarketScan (2006\u20132015). After stratifying by baseline CVD, ABA initiators were 1:1 propensity score (PS) matched to TNFi initiators to control for &gt; 60 baseline covariates. Cox proportional hazards regression estimated the HR and 95% CI for a composite endpoint of CVD including myocardial infarction, stroke\/transient ischemic stroke, or coronary revascularization in the PS-matched cohorts. HR from 2 databases were combined through an inverse variance-weighted fixed-effects model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>We included 6102 PS-matched pairs of ABA and TNFi initiators from Medicare and 6934 pairs from MarketScan. Of these, 35.3% in Medicare and 14.0% in MarketScan had baseline CVD. HR (95% CI) for composite CVD in the overall ABA group versus TNFi was 0.67 (0.55\u20130.81) in Medicare and 1.08 (0.83\u20131.41) in MarketScan with the combined HR of 0.79 (0.67\u20130.92). Among patients with baseline CVD, the HR (95% CI) was 0.71 (0.55\u20130.92) in Medicare and 1.02 (0.68\u20131.51) in MarketScan, with the combined HR of 0.79 (0.64\u20130.98).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>In this large cohort of publicly or privately insured patients with RA in the United States, ABA was associated with a 20% reduced risk of CVD versus TNFi. While this observational study is subject to potential residual confounding, our results were consistent in patients with baseline CVD.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.170926","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T11:30:33Z","timestamp":1526383833000},"page":"1240-1248","source":"Crossref","is-referenced-by-count":58,"title":["Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease"],"prefix":"10.3899","volume":"45","author":[{"given":"Yinzhu","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Ha","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Brill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi J.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoyoung C.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"issue":"Suppl 1","key":"2018112909385987000_45.9.1240.1","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","article-title":"Cardiovascular Morbidity and mortality in rheumatoid arthritis","volume":"10","author":"Gabriel","year":"2008","journal-title":"Am J Med"},{"key":"2018112909385987000_45.9.1240.2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000054612.26458.B2"},{"key":"2018112909385987000_45.9.1240.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.20853"},{"key":"2018112909385987000_45.9.1240.4","doi-asserted-by":"crossref","first-page":"33D","DOI":"10.1016\/S0002-9149(02)02235-X","article-title":"Relative risk of cardiovascular events in patients with rheumatoid arthritis","volume":"89","author":"DeMaria","year":"2002","journal-title":"Am J Cardiol"},{"key":"2018112909385987000_45.9.1240.5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"2018112909385987000_45.9.1240.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22255"},{"key":"2018112909385987000_45.9.1240.7","first-page":"435","article-title":"Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis","volume":"32","author":"Dessein","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909385987000_45.9.1240.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122226"},{"key":"2018112909385987000_45.9.1240.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes243"},{"key":"2018112909385987000_45.9.1240.10","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624"},{"key":"2018112909385987000_45.9.1240.11","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.7.1121"},{"key":"2018112909385987000_45.9.1240.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.129916"},{"key":"2018112909385987000_45.9.1240.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050524"},{"key":"2018112909385987000_45.9.1240.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035075"},{"key":"2018112909385987000_45.9.1240.15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000888"},{"key":"2018112909385987000_45.9.1240.16","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0604"},{"key":"2018112909385987000_45.9.1240.17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-012-2034-0"},{"key":"2018112909385987000_45.9.1240.18","first-page":"259","article-title":"Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis","volume":"7","author":"Mathieu","year":"2013","journal-title":"Biologics"},{"key":"2018112909385987000_45.9.1240.19","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207870"},{"key":"2018112909385987000_45.9.1240.20","doi-asserted-by":"publisher","DOI":"10.1186\/ar3260"},{"key":"2018112909385987000_45.9.1240.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.02.013"},{"key":"2018112909385987000_45.9.1240.22","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2312"},{"key":"2018112909385987000_45.9.1240.23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.113.000743"},{"key":"2018112909385987000_45.9.1240.24","doi-asserted-by":"publisher","DOI":"10.1080\/03610910902859574"},{"key":"2018112909385987000_45.9.1240.25","doi-asserted-by":"crossref","unstructured":"Kleinbaum DG Klein M . Evaluating the proportional hazards assumption. In: Survival analysis: a self-learning text, third edition. New York: Springer New York; 2012:161\u2013200.","DOI":"10.1007\/978-1-4419-6646-9_4"},{"key":"2018112909385987000_45.9.1240.26","doi-asserted-by":"crossref","unstructured":"Lee EW Wei LJ Amato DA Leurgans S . Cox-type regression analysis for large numbers of small groups of correlated failure time observations. In: Klein JP Goel PK , editors. Survival analysis: state of the art. Dordrecht: Springer Netherlands; 1992:237\u201347.","DOI":"10.1007\/978-94-015-7983-4_14"},{"key":"2018112909385987000_45.9.1240.27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nature Rev Rheumatol"},{"key":"2018112909385987000_45.9.1240.28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/pds.3953","article-title":"Identification of smoking using Medicare data \u2014 a validation study of claims-based algorithms","volume":"25","author":"Desai","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.170926","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:30:14Z","timestamp":1543519814000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.170926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,1]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.3899\/jrheum.170926"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.170926","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]}}}